Lv5
914 积分 2023-06-13 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
1天前
待确认
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
28天前
已完结
CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia
28天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
1个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
In vivo CD19-CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2个月前
已完结
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation
2个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
皖公网安备34019202002308
